The fatal trajectory of pulmonary COVID-19 is driven by lobular ischemia and fibrotic remodelling
The Lancet,
BackgroundCOVID-9 is characterized by a heterogeneous clinical presentation, ranging from mild symptoms to severe courses of…
BackgroundCOVID-9 is characterized by a heterogeneous clinical presentation, ranging from mild symptoms to severe courses of…
Ofev (nintedanib) improved microvascular architecture in a mouse model of lung fibrosis, uncovering a potential new mode of…